Medical treatment of corneal edema.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D002057:Burns, Chemical / Q000150:complications; D002908:Chronic Disease; D003261:Contact Lenses; D003315:Cornea; D065306:Corneal Injuries; D004487:Edema / Q000188:drug therapy* / Q000209:etiology; D005128:Eye Diseases / Q000188:drug therapy; D005901:Glaucoma / Q000150:complications; D005947:Glucose / Q000627:therapeutic use; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D006982:Hypertonic Solutions / Q000627:therapeutic use; D007065:Idoxuridine / Q000627:therapeutic use; D007429:Intraocular Pressure / Q000187:drug effects; D007635:Keratitis, Dendritic / Q000150:complications; D007640:Keratoconus / Q000150:complications; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D011205:Povidone / Q000627:therapeutic use; D012828:Silicones / Q000627:therapeutic use; D012965:Sodium Chloride / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000627:therapeutic use; D013666:Tears
D000305:Adrenal Cortex Hormones; D006982:Hypertonic Solutions; D009883:Ophthalmic Solutions; D012828:Silicones; D013501:Surface-Active Agents; D012965:Sodium Chloride; D011205:Povidone; D005947:Glucose; D007065:Idoxuridine; D005990:Glycerol; D001205:Ascorbic Acid